[ {
  "@id" : "_:genid1",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "http://ns.nature.com/terms/Publication"
    }, {
      "@id" : "http://purl.org/ontology/bibo/Article"
    } ]
  } ]
}, {
  "@id" : "_:genid10",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#ExperimentKit"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
    } ]
  } ]
}, {
  "@id" : "_:genid13",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
    } ]
  } ]
}, {
  "@id" : "_:genid16",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Treatment"
    } ]
  } ]
}, {
  "@id" : "_:genid20",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
    } ]
  } ]
}, {
  "@id" : "_:genid23",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
    } ]
  } ]
}, {
  "@id" : "_:genid26",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Treatment"
    } ]
  } ]
}, {
  "@id" : "_:genid29",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "http://ns.nature.com/terms/Contributor"
    }, {
      "@id" : "http://ns.nature.com/terms/Publisher"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
    } ]
  } ]
}, {
  "@id" : "_:genid34",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "http://purl.org/ontology/bibo/Article"
    }, {
      "@id" : "http://www.w3.org/2000/01/rdf-schema#Resource"
    } ]
  } ]
}, {
  "@id" : "_:genid37",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#ClinicalTrial"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Patient"
    } ]
  } ]
}, {
  "@id" : "_:genid4",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#Hypothesis"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA"
    } ]
  } ]
}, {
  "@id" : "_:genid40",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
    } ]
  } ]
}, {
  "@id" : "_:genid43",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#Disease"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Drug"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
    } ]
  } ]
}, {
  "@id" : "_:genid47",
  "@type" : [ "http://www.w3.org/2002/07/owl#AllDisjointClasses" ],
  "http://www.w3.org/2002/07/owl#members" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#AssayKit"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#AssayMethod"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#CellLine"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Chemical"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Drug"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#EasternBlotting"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#ExperimentalStudy"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Gene"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#NorthernBlotting"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#ObservationalStudy"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Probe"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Reagent"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#ReviewStudy"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#SouthernBlotting"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#WesternBlotting"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#ex_vivo"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#in_silico"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#in_vitro"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#in_vivo"
    } ]
  } ]
}, {
  "@id" : "_:genid7",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2002/07/owl#unionOf" : [ {
    "@list" : [ {
      "@id" : "https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment"
    }, {
      "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
    } ]
  } ]
}, {
  "@id" : "http://ns.nature.com/terms/Publication",
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The :Publication class groups together all individuals (or part of) created as the result of the publishing process. Note that we are not referring here to the physical artefacts, but just their abstract counterparts."
  } ]
}, {
  "@id" : "http://ns.nature.com/terms/Publisher",
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The :Publisher class represents organizations involved in the publishing business."
  } ]
}, {
  "@id" : "http://ns.nature.com/terms/name",
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid29"
  } ]
}, {
  "@id" : "http://ns.nature.com/terms/relation",
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ]
}, {
  "@id" : "http://purl.org/dc/aboutdcmi#DCMI",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/dcam/VocabularyEncodingScheme",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ]
}, {
  "@id" : "http://purl.org/dc/dcmitype/Collection",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/contributor",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/coverage",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/creator",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/format",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/identifier",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/language",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/publisher",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/relation",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/rights",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/source",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/subject",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/elements/1.1/type",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty" ]
}, {
  "@id" : "http://purl.org/dc/terms/",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2012-06-14"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "http://purl.org/dc/aboutdcmi#DCMI"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@language" : "en",
    "@value" : "DCMI Metadata Terms - other"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/Agent",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/terms/AgentClass" ]
}, {
  "@id" : "http://purl.org/dc/terms/AgentClass",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Examples of Agent Class include groups seen as classes, such as students, women, charities, lecturers."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#AgentClass-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2012-06-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A group of agents."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Agent Class"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Class"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/BibliographicResource",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#BibliographicResource-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A book, article, or other documentary resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Bibliographic Resource"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/Box",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#Box-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of regions in space defined by their geographic coordinates according to the DCMI Box Encoding Scheme."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "DCMI Box"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://dublincore.org/documents/dcmi-box/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/DCMIType",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#DCMIType-005"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2012-06-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of classes specified by the DCMI Type Vocabulary, used to categorize the nature or genre of the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "DCMI Type Vocabulary"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://purl.org/dc/dcmitype/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/DDC",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#DDC-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of conceptual resources specified by the Dewey Decimal Classification."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "DDC"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.oclc.org/dewey/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/FileFormat",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/Frequency",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#Frequency-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A rate at which something recurs."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Frequency"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/IMT",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#IMT-004"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of media types specified by the Internet Assigned Numbers Authority."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "IMT"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.iana.org/assignments/media-types/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/ISO3166",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#ISO3166-004"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of codes listed in ISO 3166-1 for the representation of names of countries."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ISO 3166"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.iso.org/iso/en/prods-services/iso3166ma/02iso-3166-code-lists/list-en1.html"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/ISO639-2",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#ISO639-2-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The three-letter alphabetic codes listed in ISO639-2 for the representation of names of languages."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ISO 639-2"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://lcweb.loc.gov/standards/iso639-2/langhome.html"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/ISO639-3",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#ISO639-3-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of three-letter codes listed in ISO 639-3 for the representation of names of languages."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ISO 639-3"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.sil.org/iso639-3/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/Jurisdiction",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/LCC",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#LCC-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of conceptual resources specified by the Library of Congress Classification."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "LCC"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://lcweb.loc.gov/catdir/cpso/lcco/lcco.html"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/LCSH",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#LCSH-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of labeled concepts specified by the Library of Congress Subject Headings."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "LCSH"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/LicenseDocument",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#LicenseDocument-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A legal document giving official permission to do something with a Resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "License Document"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "http://purl.org/dc/terms/RightsStatement"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/LinguisticSystem",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Examples include written, spoken, sign, and computer languages."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#LinguisticSystem-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A system of signs, symbols, sounds, gestures, or rules used in communication."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Linguistic System"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/Location",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/LocationPeriodOrJurisdiction",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/MESH",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#MESH-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of labeled concepts specified by the Medical Subject Headings."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MeSH"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.nlm.nih.gov/mesh/meshhome.html"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/MediaType",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/MediaTypeOrExtent",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/MethodOfAccrual",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#MethodOfAccrual-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A method by which resources are added to a collection."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Method of Accrual"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/MethodOfInstruction",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#MethodOfInstruction-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A process that is used to engender knowledge, attitudes, and skills."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Method of Instruction"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/NLM",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#NLM-002"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2005-06-13"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of conceptual resources specified by the National Library of Medicine Classification."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "NLM"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://wwwcf.nlm.nih.gov/class/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/Period",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#Period-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of time intervals defined by their limits according to the DCMI Period Encoding Scheme."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "DCMI Period"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://dublincore.org/documents/dcmi-period/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/PeriodOfTime",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/PhysicalMedium",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/PhysicalResource",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#PhysicalResource-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A material thing."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Physical Resource"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/Point",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#Point-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of points in space defined by their geographic coordinates according to the DCMI Point Encoding Scheme."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "DCMI Point"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://dublincore.org/documents/dcmi-point/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/Policy",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#Policy-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A plan or course of action by an authority, intended to influence and determine decisions, actions, and other matters."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Policy"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/ProvenanceStatement",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#ProvenanceStatement-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A statement of any changes in ownership and custody of a resource since its creation that are significant for its authenticity, integrity, and interpretation."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Provenance Statement"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/RFC1766",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#RFC1766-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of tags, constructed according to RFC 1766, for the identification of languages."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "RFC 1766"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.ietf.org/rfc/rfc1766.txt"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/RFC3066",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "RFC 3066 has been obsoleted by RFC 4646."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#RFC3066-002"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2002-07-13"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of tags constructed according to RFC 3066 for the identification of languages."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "RFC 3066"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.ietf.org/rfc/rfc3066.txt"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/RFC4646",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "RFC 4646 obsoletes RFC 3066."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#RFC4646-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of tags constructed according to RFC 4646 for the identification of languages."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "RFC 4646"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.ietf.org/rfc/rfc4646.txt"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/RFC5646",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "RFC 5646 obsoletes RFC 4646."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#RFC5646-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2010-10-11"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of tags constructed according to RFC 5646 for the identification of languages."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "RFC 5646"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.ietf.org/rfc/rfc5646.txt"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/RightsStatement",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#RightsStatement-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A statement about the intellectual property rights (IPR) held in or over a Resource, a legal document giving official permission to do something with a resource, or a statement about access rights."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Rights Statement"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/SizeOrDuration",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/Standard",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#Standard-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A basis for comparison; a reference point against which other things can be evaluated."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Standard"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/TGN",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#TGN-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of places specified by the Getty Thesaurus of Geographic Names."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "TGN"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.getty.edu/research/tools/vocabulary/tgn/index.html"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/UDC",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://purl.org/dc/dcam/VocabularyEncodingScheme" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#UDC-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of conceptual resources specified by the Universal Decimal Classification."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "UDC"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.udcc.org/"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/URI",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#URI-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of identifiers constructed according to the generic syntax for Uniform Resource Identifiers as specified by the Internet Engineering Task Force."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "URI"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.ietf.org/rfc/rfc3986.txt"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/W3CDTF",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#W3CDTF-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The set of dates and times constructed according to the W3C Date and Time Formats Specification."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "W3C-DTF"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#seeAlso" : [ {
    "@id" : "http://www.w3.org/TR/NOTE-datetime"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/abstract",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#abstract-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A summary of the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Abstract"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/description"
  }, {
    "@id" : "http://purl.org/dc/terms/description"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/accessRights",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/RightsStatement"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/rights"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/accrualMethod",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/accrualPeriodicity",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/accrualPolicy",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/alternative",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "An alternative name for the resource."
  } ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "The distinction between titles and alternative titles is application-specific."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#alternative-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2010-10-11"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "An alternative name for the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Alternative Title"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/title"
  }, {
    "@id" : "http://purl.org/dc/terms/title"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/audience",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/available",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/bibliographicCitation",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Recommended practice is to include sufficient bibliographic detail to identify the resource as unambiguously as possible."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#bibliographicCitation-002"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2003-02-15"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A bibliographic reference for the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "http://purl.org/dc/terms/BibliographicResource"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Bibliographic Citation"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/identifier"
  }, {
    "@id" : "http://purl.org/dc/terms/identifier"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/conformsTo",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/Standard"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/contributor",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Examples of a Contributor include a person, an organization, or a service."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#contributorT-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2010-10-11"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "An entity responsible for making contributions to the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Contributor"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/Agent"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/contributor"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/coverage",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Spatial topic and spatial applicability may be a named place or a location specified by its geographic coordinates. Temporal topic may be a named period, date, or date range. A jurisdiction may be a named administrative entity or a geographic place to which the resource applies. Recommended best practice is to use a controlled vocabulary such as the Thesaurus of Geographic Names [TGN]. Where appropriate, named places or time periods can be used in preference to numeric identifiers such as sets of coordinates or date ranges."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#coverageT-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Coverage"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/LocationPeriodOrJurisdiction"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/coverage"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/created",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/creator",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Examples of a Creator include a person, an organization, or a service."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#creatorT-002"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2010-10-11"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "An entity primarily responsible for making the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "http://purl.org/ontology/bibo/Article"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Creator"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/Agent"
  }, {
    "@id" : "http://www.w3.org/2000/10/swap/pim/contact#Person"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/creator"
  }, {
    "@id" : "http://purl.org/dc/terms/contributor"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/date",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/dateAccepted",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/dateCopyrighted",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/dateSubmitted",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/description",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Description may include but is not limited to: an abstract, a table of contents, a graphical representation, or a free-text account of the resource."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#descriptionT-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "An account of the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/ScienceOnto/phm#ResearchStatement"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Description"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2001/XMLSchema#string"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/description"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/educationLevel",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/extent",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/SizeOrDuration"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/format"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/format",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/MediaTypeOrExtent"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/format"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/hasFormat",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/hasPart",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#hasPart-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A related resource that is included either physically or logically in the described resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Has Part"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  }, {
    "@id" : "http://purl.org/dc/terms/relation"
  } ],
  "http://www.w3.org/2004/02/skos/core#note" : [ {
    "@language" : "en",
    "@value" : "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/hasVersion",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/identifier",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Recommended best practice is to identify the resource by means of a string conforming to a formal identification system."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#identifierT-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "An unambiguous reference to the resource within a given context."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Identifier"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/identifier"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/instructionalMethod",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/isFormatOf",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/isPartOf",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#isPartOf-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A related resource in which the described resource is physically or logically included."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Is Part Of"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  }, {
    "@id" : "http://purl.org/dc/terms/relation"
  } ],
  "http://www.w3.org/2004/02/skos/core#note" : [ {
    "@language" : "en",
    "@value" : "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/isReferencedBy",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#isReferencedBy-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A related resource that references, cites, or otherwise points to the described resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Is Referenced By"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  }, {
    "@id" : "http://purl.org/dc/terms/relation"
  } ],
  "http://www.w3.org/2004/02/skos/core#note" : [ {
    "@language" : "en",
    "@value" : "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/isReplacedBy",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/isRequiredBy",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/isVersionOf",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Changes in version imply substantive changes in content rather than differences in format."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#isVersionOf-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A related resource of which the described resource is a version, edition, or adaptation."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Is Version Of"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  }, {
    "@id" : "http://purl.org/dc/terms/relation"
  } ],
  "http://www.w3.org/2004/02/skos/core#note" : [ {
    "@language" : "en",
    "@value" : "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/issued",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/language",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Recommended best practice is to use a controlled vocabulary such as RFC 4646 [RFC4646]."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#languageT-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A language of the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Language"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/LinguisticSystem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/language"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/license",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/LicenseDocument"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/rights"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/mediator",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/medium",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/PhysicalMedium"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/format"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/modified",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/provenance",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/publisher",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "An entity responsible for making the resource available."
  } ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Examples of a Publisher include a person, an organization, or a service."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#publisherT-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2010-10-11"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "An entity responsible for making the resource available."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "http://ns.nature.com/terms/Publication"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Publisher"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/Agent"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/publisher"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/references",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#references-003"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2000-07-11"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A related resource that is referenced, cited, or otherwise pointed to by the described resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "References"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  }, {
    "@id" : "http://purl.org/dc/terms/relation"
  } ],
  "http://www.w3.org/2004/02/skos/core#note" : [ {
    "@language" : "en",
    "@value" : "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/relation",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Recommended best practice is to identify the related resource by means of a string conforming to a formal identification system."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#relationT-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A related resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Relation"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ],
  "http://www.w3.org/2004/02/skos/core#note" : [ {
    "@language" : "en",
    "@value" : "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/replaces",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/requires",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/relation"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/rights",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/RightsStatement"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/rights"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/rightsHolder",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "http://purl.org/dc/terms/source",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/source"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/spatial",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/Location"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/coverage"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/subject",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Typically, the subject will be represented using keywords, key phrases, or classification codes. Recommended best practice is to use a controlled vocabulary."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#subjectT-002"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2012-06-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The topic of the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Subject"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/subject"
  } ],
  "http://www.w3.org/2004/02/skos/core#note" : [ {
    "@language" : "en",
    "@value" : "This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration."
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/tableOfContents",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/description"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/temporal",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://purl.org/dc/terms/PeriodOfTime"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/coverage"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/title",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A name given to the resource."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#titleT-002"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2010-10-11"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "A name given to the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid1"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Title"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/title"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/type",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/terms/description" : [ {
    "@language" : "en",
    "@value" : "Recommended best practice is to use a controlled vocabulary such as the DCMI Type Vocabulary [DCMITYPE]. To describe the file format, physical medium, or dimensions of the resource, use the Format element."
  } ],
  "http://purl.org/dc/terms/hasVersion" : [ {
    "@id" : "http://dublincore.org/usage/terms/history/#typeT-001"
  } ],
  "http://purl.org/dc/terms/issued" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://purl.org/dc/terms/modified" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#date",
    "@value" : "2008-01-14"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The nature or genre of the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#isDefinedBy" : [ {
    "@id" : "http://purl.org/dc/terms/"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Type"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Class"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/type"
  } ]
}, {
  "@id" : "http://purl.org/dc/terms/valid",
  "@type" : [ "http://www.w3.org/2002/07/owl#AnnotationProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://purl.org/dc/elements/1.1/date"
  } ]
}, {
  "@id" : "http://purl.org/ontology/bibo/abstract",
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A summary of the resource."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid34"
  } ]
}, {
  "@id" : "http://www.w3.org/2000/10/swap/pim/contact#Person",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ]
}, {
  "@id" : "http://www.w3.org/2001/XMLSchema#date",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype" ]
}, {
  "@id" : "http://www.w3.org/2001/XMLSchema#gYear",
  "@type" : [ "http://www.w3.org/2000/01/rdf-schema#Datatype" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm",
  "@type" : [ "http://www.w3.org/2002/07/owl#Ontology" ],
  "http://purl.org/dc/elements/1.1/creator" : [ {
    "@value" : "Zeynep Say, Aysegul Say, Sahar Vahdati, Said Fathalla"
  } ],
  "http://purl.org/dc/terms/license" : [ {
    "@value" : "Creative Commons Attribution 3.0 (CC BY 3.0)"
  } ],
  "http://www.w3.org/2002/07/owl#imports" : [ {
    "@id" : "http://ns.nature.com/terms/"
  }, {
    "@id" : "http://purl.org/ontology/bibo/"
  }, {
    "@id" : "http://xmlns.com/foaf/0.1/"
  } ],
  "http://www.w3.org/2002/07/owl#versionInfo" : [ {
    "@value" : "2.0"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@value" : "PharmSci is an Ontology for describing Pharmaceutical Science research.\nThe aim of building ontology is to help Pharmaceutical Science researchers to find scientific research close to their work or their research topic. Ontology covers the study design for the pharmaceutical science research which is a Clinical Study includes experimental and non-experimental studies."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Patient" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "10_patients_with_acute_lymphocytic_leukemia"
  } ],
  "https://w3id.org/SKGO/phm#hasDisease" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Leukaemia"
  } ],
  "https://w3id.org/SKGO/phm#has_Treatment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#50_patients_with_newly_diagnosed_AML",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Patient" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "50_patients_with_newly_diagnosed_AML"
  } ],
  "https://w3id.org/SKGO/phm#hasDisease" : [ {
    "@id" : "https://w3id.org/SKGO/phm#AML"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#795-bp_cDNA",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Probe" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "795-bp_cDNA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#99mTc-labeled_compounds_were_exported_via_MRP24_and_BCRP",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "99mTc-labeled_compounds_were_exported_via_MRP24_and_BCRP"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "We examinedwhether 99mTc-labeled compounds were\nexported via MRP24 and BCRP and whether these compounds\nhad affinity for these transporters including MDR1\nand MRP1 in cancer cells."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#A._T._FoJo",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "A. T. Fojo"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ABCA2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ABCA2"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ABC_genes",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ABC_genes"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ABC_transporters_and_in_vitro_MDR"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentMethod" : [ {
    "@id" : "https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#CAVE"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Cyclosporine"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Cytarabine"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Daunorubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Epirubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Etoposide"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#IL-2"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Mitoxantrone"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Paclitaxel"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#VAD"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Vindesine"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#CAV/EP"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://ns.nature.com/terms/publicationYear" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#gYear",
    "@value" : "2005"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Cheol-Hee_Choi"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Cancer_Cell_International"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "ABC transporters as multidrug resistance mechanisms and the\ndevelopment of chemosensitizers for their reversal"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "One of the major problems related with anticancer chemotherapy is resistance against anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter proteins that are responsible for drug resistance and a low bioavailability of drugs by pumping a variety of drugs out cells at the expense of ATP hydrolysis. One strategy for reversal of the resistance of tumor cells\nexpressing ABC transporters is combined use of anticancer drugs with chemosensitizers. In this review, the physiological functions and structures of ABC transporters, and the development of chemosensitizers are described focusing on well-known proteins including P-glycoprotein, multidrug resistance associated protein, and breast cancer resistance protein."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://ns.nature.com/terms/name" : [ {
    "@value" : "MULTIDRUG RESISTANCE IN CANCER"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ABC transporters in human cancers"
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Leukaemia"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Lung_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Non_Smallcell_Lung_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Small_Cell_Lung_Cancer"
  } ],
  "https://w3id.org/SKGO/phm#investigatesProblem" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Drug_Resistance"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ADE",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ADE"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ALL",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ALL"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AML",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "AML"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AML_sample",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "AML_sample"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfromPatient" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ARUN_K._RISHI",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Arun k. Rishi"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://purl.org/dc/terms/description" : [ {
    "@value" : "The hypothesis that an ATPdependent xenobiotic transporter may contribute significantly to the multidrug-resistance phenotype of MCF-7yAdrVp cells."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://ns.nature.com/terms/publicationYear" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#gYear",
    "@value" : "1998"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ARUN_K._RISHI"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#L._AUSTIN_DOYLE"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#LYNNE_V._ABRUZZO"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#TAMMY_KROGMANN"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#WEIDONG_YANG"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#YONGMING_GAO"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "A multidrug resistance transporter from human MCF-7 breast cancer cells"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@language" : "en",
    "@value" : "MCF-7yAdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent reduction in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein. RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in\nMCF-7yAdrVp cells relative to parental MCF-7 cells. The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP). Enforced expression of the full-length\nBCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123\nin the cloned transfected cells. BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7yAdrVp human breast cancer cells."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Accumulation_Bioassay",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Accumulation_Bioassay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Actinomycin_D",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Actinomycin_D"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Acute_lymphoblastic_leukemia",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Acute_lymphoblastic_leukemia"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Adrenocortical_Cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Adrenocortical_Cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Advanced_and_recurrent_breast_cancer_sample",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Advanced_and_recurrent_breast_cancer_sample"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfromPatient" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#American_Type_Culture_Collection",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Organization" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Analysis_of_leukemic_blast_MDR_function"
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#AML"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Leukaemia"
  } ],
  "https://w3id.org/SKGO/phm#investigatesProblem" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Anthracyclines-doxorubucin_daunorubicin_epirubicin",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Anthracyclines-doxorubucin_daunorubicin_epirubicin"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Anthranilic-acid-based_drug",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Anthranilic-acid-based_drug"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "An experimental method is a way to solve a scientific task by executing a scientific experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ExperimentMethod"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "An experimental method is a way to solve a scientific task by executing a scientific experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Assay",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A set of instructions, methodology, operations, required reagents, instruments to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Assay"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A set of instructions, methodology, operations, required reagents, instruments to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The title of the kit/biologicals used in the assay."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "AssayKit"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Assay"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The title of the kit/biologicals used in the assay."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "AssayKit"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit15",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit16",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit17",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit18",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit19",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit20",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayKit9",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#AssayMethod",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The methods required to perform typical screening assay. Assay methods include laboratory methods."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "AssayMethod"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Assay"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The methods required to perform typical screening assay. Assay methods include laboratory methods."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "AssayMethod"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Asuka_Mizutani",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Asuka Mizutani"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#BBR3390",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "BBR3390"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#BCRP",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "BCRP"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "BCRP_substrate/inhibitors"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BBR3390"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#CI1033"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Daunorubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Doxorubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Epirubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Flavopiridol"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Iamivudine"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Idarubicinol"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Indolocarbazole"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Methotrexate"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Mitoxantrone"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Prazocin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Topotecan"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Zidovudine"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#topoisomerase_I"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#BD_Biosciences_La_Jolla_CA",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Organization" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#BH3_profiling",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "BH3_profiling"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentMethod" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BH3_profiling_method"
  } ],
  "https://w3id.org/SKGO/phm#useCellLine" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Gastrointestinal_stromal_tumour_GIST_cell_lines"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Melanoma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Pancreatic_cancer_cell_lines"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#ERBB2amplified_breast_cancer_cell_lines"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Bevacizumab"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Bortezomib"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Cetuximab"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Crizotinib"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Dasatinib"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Gefitinib"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Nilotinib"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Trastuzumab"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Vemurafenib"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#BH3_profiling_method",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "BH3_profiling_method"
  } ],
  "https://w3id.org/SKGO/phm#useAssay" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Functional_Assay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Bevacizumab",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Bevacizumab"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Blast_populations_in_the_two_bioassays",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#StatisticalAnalysis" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Blast populations in the two bioassays"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "P-gp accumulation ratio, P-gp efflux ratio, percent unimpeded efflux for total MDR activity, percent efflux in the presence of zosuquidar, and percent inhibition of efflux by zosuquidar"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#BlotAnalysis",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The transfer of protein, RNA or DNA molecules from a thick acrylamide or agarose gel to a paper like membrane by capilliarity or an electric field, preserving the spatial arrangement."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "BlotAnalysis"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The transfer of protein, RNA or DNA molecules from a thick acrylamide or agarose gel to a paper like membrane by capilliarity or an electric field, preserving the spatial arrangement."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Bone_marrow_aspirates",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Bone_marrow_aspirates"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfrom" : [ {
    "@id" : "https://w3id.org/SKGO/phm#50_patients_with_newly_diagnosed_AML"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Bortezomib",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Bortezomib"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Branimir_I._Sikic",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Branimir I. Sikic"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Breast_Cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Breast_cancer_samples",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Breast_cancer_samples"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfromPatient" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CAV/EP",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "CAV/EP"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CAVE",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "CAVE"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CCL_127__PC12",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "CCL_127__PC12"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CD34+_Leukemic_Blasts",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "CD34+_Leukemic_Blasts"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CD56+",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "CD56+"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CI1033",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "CI1033"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CLONTECH",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Organization" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CML",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "CML"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Caitriona_Holohan",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Caitriona Holohan"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Calculations",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Cancer_Cell_International",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publisher" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Treatment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Cancer_chemotherapy_doxorubicin_vinblastine"
  } ],
  "https://w3id.org/SKGO/phm#treatmentOutcome" : [ {
    "@language" : "en",
    "@value" : "Vinca alkaloid, doxorubicin, or actinomycin D might not be effective in the therapy of pheochromocytoma."
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Actinomycin_D"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Doxorubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Mitomycin_C"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Vincristine"
  } ],
  "https://w3id.org/SKGO/phm#useSpecimen" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Peripheral_blood_lymphocytes"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Cancer_drug_resistance_an_evolving_paradigm",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Caitriona_Holohan"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Daniel_B._Longley"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Patrick_G._Johnston"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Sandra_Van_Schaeybroeck"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@language" : "en",
    "@value" : "Cancer drug resistance: an evolving paradigm"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@language" : "en",
    "@value" : "Resistance to chemotherapy and molecularly targeted therapies is a major\nproblem facing current cancer research. The mechanisms of resistance to classical cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific molecular targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. With the increasing arsenal of anticancer agents, improving preclinical models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug\nresistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Carboplatin",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Carboplatin"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Catherine_Booth-Genthe",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Catherine Booth Genthe"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Cell",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Cell"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#CellLine",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "CellLine"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The term 'line' is used when a culture has undergone an intentional experimental process to establish a more uniform and stable population of cells."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Cetuximab",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Cetuximab"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Chemical",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Chemical"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A substance composed of chemical elements."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Chemotherapy",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Treatment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Chemotherapy"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Treatment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"
  } ],
  "https://w3id.org/SKGO/phm#useSpecimen" : [ {
    "@id" : "https://w3id.org/SKGO/phm#AML_sample"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Advanced_and_recurrent_breast_cancer_sample"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#NSCLC_sample"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Poor-risk_acute_leukaemia_samples"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Refractory_AML_high-risk_MDS_sample"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Relapsed_and_refractory_AML_sample"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Cheol-Hee_Choi",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Cheol Hee Choi"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblem",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A difficulty, disorder, or condition needing resolution."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A difficulty, disorder, or condition needing resolution."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution10",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution11",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution12",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution13",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution14",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution15",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution16",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution17",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution18",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution19",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution20",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalProblemSolution9",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A research study involving human subjects designed to answer specific questions about the safety and efficacy of a biomedical intervention (drug, treatment, device), or new ways of using a known drug, treatment or device."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A research study involving human subjects designed to answer specific questions about the safety and efficacy of a biomedical intervention (drug, treatment, device), or new ways of using a known drug, treatment or device."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ClinicalTrial",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Clinical trial an experiment performed on human beings in order to evaluate the comparative efficacy of two or more therapies."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ClinicalTrial"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Clinical trial an experiment performed on human beings in order to evaluate the comparative efficacy of two or more therapies."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Clonogenic_survival_assays",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Clonogenic_survival_assays"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Colchicine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Colchicine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Colerectal_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Colerectal_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Colon_Tumor",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Colerectal_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Colon_carcinoma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Colon_carcinoma"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfrom" : [ {
    "@id" : "https://w3id.org/SKGO/phm#National_Cancer_Institute"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Comparative_CD34+_blast_responses_were_examined"
  } ],
  "https://w3id.org/SKGO/phm#useAssay" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Accumulation_Bioassay"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Efflux_Bioassay"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Functional_Bioassay"
  } ],
  "https://w3id.org/SKGO/phm#useStatisticalAnalysis" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Blast_populations_in_the_two_bioassays"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Crizotinib",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Crizotinib"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Cyclosporine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Cyclosporine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Cytarabine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Cytarabine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#D._G._POPLACK",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "D. G. Poplack"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#D._J._SLAMON",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "D. J. Slamon"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Douglas D. Ross"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Daniel_B._Longley",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Daniel B. Longley"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Dasatinib",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Dasatinib"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Daunomycin",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Daunomycin"
  } ],
  "http://www.w3.org/2002/07/owl#sameAs" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Daunorubicin"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Daunorubicin",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Daunorubicin"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Delta_RNA_Fingerprinting_kit",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ExperimentKit" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Delta_RNA_Fingerprinting_kit"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfrom" : [ {
    "@id" : "https://w3id.org/SKGO/phm#CLONTECH"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Describe_various_approaches_to_combating_multidrug-resistant_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://purl.org/dc/terms/description" : [ {
    "@value" : "The most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Describe_various_approaches_to_combating_multidrug-resistant_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#DiOC2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Reagent" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "DiOC2"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfrom" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Invitrogen"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://ns.nature.com/terms/publicationYear" : [ {
    "@language" : "en",
    "@value" : "2018"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Asuka_Mizutani"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Ikumi_Tamai"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Kazuki_Fukuchi"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Keiichi_Kawai"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Kodai_Nishi"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Masato_Kobayashi"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Ryuichi_Nishii"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Takafumi_Tsujiuchi"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Takeo_Nakanishi"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Yuya_Okui"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Springer_Science+Business_Media_LLC"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@language" : "en",
    "@value" : "Different Efflux Transporter Aff inity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@language" : "en",
    "@value" : "Background Little is known about the affinity and stability of\n99mTc-labeled 2-methoxyisobutylisonitrile (99mTc-MIBI) and\ntetrofosmin (99mTc-TF) for imaging of multiple drug resistance\ntransporters in cancer. We examined the affinity of 99mTc-labeled\ncompounds for these transporters and their stability.\nMethods 99mTc-MIBI and 99mTc-TF were incubated in vesicles\nexpressing P-glycoprotein (MDR1), multidrug resistanceassociated\nprotein (MRP)14, or breast cancer resistance protein\nwith and without verapamil (MDR1 inhibitor) or MK-\n571 (MRP inhibitor). Time activity curves of 99mTc-labeled\ncompounds were established using SK-N-SH neuroblastoma,\nSK-MEL-28 melanoma, and PC-3 prostate adenocarcinoma\ncell lines, and transporter expression of multiple drug resistance\nwas measured in these cells. The stability was evaluated.\nResults In vesicles, 99mTc-labeled compounds had affinity for\nMDR1 and MRP1. 99mTc-TF had additional affinity for\nMRP2 and MRP3. In SK-N-SH cells expressing MDR1 and\nMRP1, MK-571 produced the highest uptake of both 99mTclabeled\ncompounds. 99mTc-MIBI uptake with inhibitors was\nhigher than 99mTc-TF uptake with inhibitors. 99mTc-TF was\ntaken up more in SK-MEL-28 cells expressing MRP1 and\nMRP2 than PC-3 cells expressing MRP1 and MRP3. 99mTc-\nMIBI was metabolized, whereas 99mTc-TF had high stability.\nConclusion 99mTc-MIBI is exported via MDR1 and MRP1\n(MRP1 > MDR1) at greater levels and more quickly compared\nto 99mTc-TF, which is exported via MDR1 and MRP13\n(MRP1 > MDR1; MRP1, 2 >MRP3). Because 99mTc-MIBI\nis metabolized, clinical imaging for monitoring MDR and\nshorter examination times may be possible with an earlier scanning\ntime on late phase imaging. 99mTc-TF has high stability\nand accurately reflects the function of MDR1 and MRP13."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_Resistance_Monitoring_in_Cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Treatment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"
  } ],
  "https://w3id.org/SKGO/phm#treatmentOutcome" : [ {
    "@language" : "en",
    "@value" : "There was increased intracellular\naccumulation of doxorubicin as was evidenced using\nconfocal microscopy and reduced toxicity compared to the\nfree (unencapsulated) doxorubicin."
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Daunorubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Leukotriene_C4"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Taurocholate"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://ns.nature.com/terms/name" : [ {
    "@value" : "A multidrug resistance transporter from human MCF-7 breast cancer cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "MCF-7/AdrVp is a multidrug-resistant human\nbreast cancer subline that displays an ATP-dependent\nreduction in the intracellular accumulation of anthracycline\nanticancer drugs in the absence of overexpression of known\nmultidrug resistance transporters such as P glycoprotein or\nthe multidrug resistance protein."
  } ],
  "https://w3id.org/SKGO/phm#hasSuggestion" : [ {
    "@language" : "en",
    "@value" : "The presence of the phosphopantetheine attachment site on BCRP suggests\nthat BCRP may be part of a multiprotein complex."
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Disease",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A definite pathological process having a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Disease"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A definite pathological process having a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Doxorubicin",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Doxorubicin"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Drosophila_white_gene",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Drosophila_white_gene"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Drug",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Drug"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Therapeutic agent; any substance, other than food, used in the prevention, diagnosis, alleviation, treatment, or cure of disease. For types or classifications of drugs, see the specific name."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Drug_Resistance",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalProblem" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Drug_Resistance"
  } ],
  "https://w3id.org/SKGO/phm#hasMutationResult" : [ {
    "@value" : "Dubin-Johnson syndrome"
  } ],
  "https://w3id.org/SKGO/phm#hasTissueLocalization" : [ {
    "@value" : "Liver, kidney, intestine, adrenal glands, pancreas, lung, ovary"
  } ],
  "https://w3id.org/SKGO/phm#name" : [ {
    "@value" : "Drug Resistance"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://ns.nature.com/terms/name" : [ {
    "@value" : "Targeting multidrug resistance in cancer"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#AML"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Leukaemia"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Lung_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Myeloma"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ABC_transporters_and_in_vitro_MDR"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Drug_resistance_and_its_role_in_clinical_oncology",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://purl.org/dc/terms/description" : [ {
    "@value" : "Cellular mechanisms of multidrug resistance and ATP-binding cassette (ABC) transporters"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Drug_resistance_and_its_role_in_clinical_oncology"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ERBB2amplified_breast_cancer_cell_lines",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ERBB2_amplified_breast_cancer_cell_lines"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#EasternBlotting",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "EasternBlotting"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BlotAnalysis"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "EasternBlotting"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Eastern_Blot_Analysis",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#EasternBlotting" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Eastern_Blot_Analysis"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Efflux_Bioassay",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Efflux_Bioassay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Elisabeth_Paietta",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@value" : "Elisabeth Paietta"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Endogenous_and_exogenous_substrates_for_ABC_transporters"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Actinomycin_D"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Anthracyclines-doxorubucin_daunorubicin_epirubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Colchicine"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Methotrexate"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Podophyllotoxin-etoposide_teniposide"
  } ],
  "https://w3id.org/SKGO/phm#useGene" : [ {
    "@id" : "https://w3id.org/SKGO/phm#MRP1"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP2"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP3"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP4"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP5"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP6"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP7"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP8"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#mdr1"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Epirubicin",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Epirubicin"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Etoposide",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Etoposide"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#European_Journal_of_Pharmaceutical_Sciences",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publisher" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence17",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence18",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence19",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence20",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence9",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://purl.org/dc/elements/1.1/title" : [ {
    "@language" : "en",
    "@value" : "Evidence of a Role for Functional Heterogeneity in\nMultidrug Resistance Transporters in Clinical Trials of\nP-Glycoprotein Modulation in Acute Myeloid Leukemia"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Branimir_I._Sikic"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Elisabeth_Paietta"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#John_F._Marcelletti"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Larry_D._Cripe"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#International_Clinical_Cytometry_Society"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@language" : "en",
    "@value" : "Background: Multidrug resistance (MDR) transporter proteins such as P-glycoprotein (P-gp) efflux a variety\nof chemotherapeutic drugs from acute myeloid leukemia (AML) blasts leading to clinical drug resistance.\nMethods: This study examined heterogeneity of MDR functional efflux by AML blasts using two flow cytometry\nbioassays. Bone marrow specimens (N = 50) from elderly patients with newly diagnosed AML were analyzed\nfor CD34+ blasts with MDR efflux function. Efflux was measured with a fluorescent dye (DiOC2) as a\nsurrogate for oncology drugs that are substrates for MDR efflux. P-gp-mediated efflux was differentiated from\nnon-P-gp MDR activities using zosuquidar, a highly selective P-gp modulator. The bioassays included a\nzosuquidar-dependent DiOC2 accumulation bioassay that measured only P-gp. The second method, termed the\nefflux bioassay, could detect P-gp and other non-P-gp efflux depending on bioassay culture conditions.\nResults: Sixty-two percent of the specimens were considered positive for blasts with P-gp function, and\n26% of such P-gp-positive specimens also exhibited zosuquidar-resistant (i.e., non-P-gp) MDR efflux activity;\n37% of P-gp-negative AML blast specimens displayed zosuquidar-resistant MDR function in the efflux\nbioassay.\nConclusions: These results confirm the heterogeneous nature of MDR efflux pumps in AML blasts, and provide\nsupport for the hypothesis that non-P-gp MDR contributed to negative results with zosuquidar in AML trials\nlike ECOG-ACRIN E3999."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Analysis_of_leukemic_blast_MDR_function"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ExperimentKit",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The title of the kit/biologicals used in the experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ExperimentKit"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The title of the kit/biologicals used in the experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Materials are culture collections and chemicals used for executing of an experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ExperimentMaterial"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Materials are culture collections and chemicals used for executing of an experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ExperimentSetting",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A designed experiment involves the investigator assigning (preferably randomly) some or all conditions to subjects."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ExperimentSetting"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A designed experiment involves the investigator assigning (preferably randomly) some or all conditions to subjects."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ExperimentalStudy",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Any Study conducted with a scientific approach, where a set of variables are kept constant while the other set of variables are being measured as the subject of experiment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ExperimentalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#StudyDesign"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Any Study conducted with a scientific approach, where a set of variables are kept constant while the other set of variables are being measured as the subject of experiment"
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "ExperimentalStudy"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Experimental_Study",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ExperimentalStudy" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Experimental Study"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://ns.nature.com/terms/name" : [ {
    "@value" : "Expression of a multidrug-resistance gene in human tumors and tissues"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Expression_of_a_multidrug-resistance_gene"
  } ],
  "https://w3id.org/SKGO/phm#hasSuggestion" : [ {
    "@value" : "Some cases of colon cancer, increased expression of the mdr1 gene might be involved in the intrinsic resistance of these tumors to chemotherapeutic agents."
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Adrenocortical_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Colon_Tumor"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Neuroblastoma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Neuroepithelioma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Pheochromocytoma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Rhabdomyosarcoma"
  } ],
  "https://w3id.org/SKGO/phm#investigatesProblem" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multiple_chemotherapeutic_agents"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#mdr1_gene_expression"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://ns.nature.com/terms/publicationYear" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#gYear",
    "@value" : "1987"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#D._G._POPLACK"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#D._J._SLAMON"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#I._PASTAN"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#K._UEDA"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#M._M._GOTTESMAN"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "Expression of a multidrug-resistance gene in human tumors and tissues"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@value" : "The identification and cloning of a segment of a human multidrug resistance gene (mdrl) was reported recently. To examine the molecular basis of one type of multidrug resistance, we have prepared RNA from human tumors and normal tissues and measured their content of mdrl RNA. We find that the mdrl gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at\nintermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues. The mdrl gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon. In addition, increased expression was detected in a few tumors at the time of relapse following initial chemotherapy. Although controlled clinical studies will be required, our results suggest that measurement of mdrl RNA may prove to be a valuable tool in the design of chemotherapy protocols."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Expression_of_a_multidrug-resistance_gene"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding10",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding11",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding12",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding13",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding14",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding15",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding16",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding17",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding18",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding19",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding20",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Finding9",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Flavopiridol",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Flavopiridol"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Fluorochrome-labeled_anti-CD_antibodies",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Reagent" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Fluorochrome-labeled_anti-CD_antibodies"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfrom" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BD_Biosciences_La_Jolla_CA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Fluorouracil",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Fluorouracil"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Functional_Assay",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Functional_Assay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Functional_Bioassay",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Functional_Bioassay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Treatment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Functions_of_ABC_transporters_in_Chemotherapy"
  } ],
  "https://w3id.org/SKGO/phm#failureReason" : [ {
    "@value" : "PGP expression increased after therapy and was associated with a greater likelihood of treatment failure."
  } ],
  "https://w3id.org/SKGO/phm#treatmentOutcome" : [ {
    "@value" : "Toxicity"
  } ],
  "https://w3id.org/SKGO/phm#useSpecimen" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Breast_cancer_samples"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Gastrointestinal_stromal_tumour_GIST_cell_lines",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Gastrointestinal_stromal_tumour_GIST_cell_lines"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Gefitinib",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Gefitinib"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Gene",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Gene"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "One of the biologic units of heredity, self-reproducing, and located at a definite position (locus) on a particular chromosome."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Gergely_Szakcs",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Growth_inhibition_assays",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Growth_inhibition_assays"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#HTB_10_HTB_11_HTB_38",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "HTB_10_HTB_11_HTB_38"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Head_and_neck_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Head_and_neck_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#High-risk_MDS_sample",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "High-risk_MDS_sample"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Hypothesis",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A supposition that appears to explain a group of phenomena and is advanced as a bases for further investigation."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Hypothesis"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A supposition that appears to explain a group of phenomena and is advanced as a bases for further investigation."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#I._PASTAN",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#IL-2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "IL-2"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Iamivudine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Iamivudine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Idarubicine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Idarubicine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Idarubicinol",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Idarubicinol"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"
  } ],
  "https://w3id.org/SKGO/phm#hasStudyDesign" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Review_Study"
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#AML"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BCRP_substrate/inhibitors"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Ifosfamide",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Ifosfamide"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Ikumi_Tamai",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Imatinib",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Imatinib"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Immunosuppressant_cyclosporin_A",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Immunosuppressant_cyclosporin_A"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Indolocarbazole",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Indolocarbazole"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#International_Clinical_Cytometry_Society",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publisher" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Investigation",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Investigation is the process of carrying out a plan or procedure so as to discover facts or information about the object of study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Investigation"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Investigation is the process of carrying out a plan or procedure so as to discover facts or information about the object of study."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Invitrogen",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Organization" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Jill_K._Paterson",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#John_F._Marcelletti",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Joseph_A._Ludwig",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#K._UEDA",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#KB-3-1_KB-8-5_KB-V1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "KB-3-1_KB-8-5_KB-V1"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Kazuki_Fukuchi",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Keiichi_Kawai",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Kodai_Nishi",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#L._AUSTIN_DOYLE",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#LYNNE_V._ABRUZZO",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Larry_D._Cripe",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Lawrence_D._Mayer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Leukaemia",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Leukaemia"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Leukotriene_C4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Leukotriene_C4"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Levels_of_mdrl_mRNA",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://purl.org/dc/terms/description" : [ {
    "@value" : "Since expression of the mdrl gene is responsible for multidrug resistance in tissue culture systems, we measured levels of mdrl mRNA in normal human tissues and in untreated and treated human cancers."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Levels_of_mdrl_mRNA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Lung_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Lung_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Lymphoma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Lymphoma"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#M._M._GOTTESMAN",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MCF-7/AdrVp_comparison",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MCF-7/AdrVp_comparison"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentKit" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Delta_RNA_Fingerprinting_kit"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentMethod" : [ {
    "@id" : "https://w3id.org/SKGO/phm#RNA_Fingerprinting"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentalResult" : [ {
    "@language" : "en",
    "@value" : "Sensitivity of selected MCF-7 sublines to antineoplastic agents determined by sulforhodamine-B cytotoxicity assay (21). Experiments such as those\ndisplayed in Figure 4D were used to obtain the LC50. For each drug and cell type, the table displays the median LC50 and range of LC50 measurements\n(nM), the number of experimental determinations of LC50 that were performed (N), and the resistance factor (RF). The RF was calculated by\ndividing the median LC50 for a given drug against a transfected cell line by the median LC50 of that drug against nontransfected MCF-7yW cells.\nFor each drug tested, the LC50 for the BCRP-transfected cells was examined for statistically significant difference from the LC50 of MCF-7yW or\nMCF-7ypcDNA3 by the MannWhitney test, using MINITAB statistical software MINITAB release 8 extended, Minitab, State College, PA) and a 95%\nconfidence interval. The values of P for the statistically significant differences are as follows Mitoxantrone: MCF-7yW vs. MCF-7yBCRPclone6,\nP 5 0.0107, MCF-7yW vs. MCF-7yBCRPclone8, P 5 0.0058, MCF-7ypcDNA3 vs. MCF-71BCRPclone6, P 5 0.0142, MCF-7ypcDNA3 vs.\nMCF-7yBCRPclone8, P 5 0.0081; daunorubicin: MCF-7yW vs. MCF-7yBCRPclone6, P 5 0.0107, MCF-7yW vs. MCF-7yBCRPclone8, P 5\n0.0058, MCF-7ypcDNA3 vs. MCF-7yBCRPclone6, P 5 0.0195, MCF-7ypcDNA3 vs. MCF-7yBCRPclone8, P 5 0.0163; doxorubicin: MCF-7yW\nvs. MCF-7yBCRPclone6, P 5 0.0373, MCF-7yW vs. MCF-7yBCRPclone8, P 5 0.02, MCF-7ypcDNA3 vs. MCF-7yBCRPclone8, P 5 0.0304;\ncis-platin: MCF-7yW vs. MCF-7yBCRPclone19, P 5 0.0497."
  } ],
  "https://w3id.org/SKGO/phm#useCellLine" : [ {
    "@id" : "https://w3id.org/SKGO/phm#MCF-7_human_breast_carcinoma_cells"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Daunorubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Doxorubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Mitoxantrone"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Paclitaxel"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Vincristine"
  } ],
  "https://w3id.org/SKGO/phm#useProbe" : [ {
    "@id" : "https://w3id.org/SKGO/phm#795-bp_cDNA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MCF-7_human_breast_carcinoma_cells",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MCF-7_human_breast_carcinoma_cells"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfrom" : [ {
    "@id" : "https://w3id.org/SKGO/phm#National_Cancer_Institute"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MDR2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MDR2"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MRP1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MRP1"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MRP2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MRP2"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MRP3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MRP3"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MRP4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MRP4"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MRP5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MRP5"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MRP6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MRP6"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MRP7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MRP7"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MRP8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MRP8"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://ns.nature.com/terms/publicationYear" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#gYear",
    "@value" : "2002"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Michael_M._Gottesman"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Susan_E._Bates"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Tito_Fojo"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@value" : "Chemotherapeutics are the most effective treatment for metastatic tumours. However, the ability of cancer cells to become simultaneously resistant to different drugs  a trait known as multidrug resistance  remains a significant impediment to successful chemotherapy. Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents. Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ABC_transporters_in_human_cancers"
  } ],
  "https://w3id.org/SKGO/phm#hasTitle" : [ {
    "@language" : "en",
    "@value" : "MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Macmillan_Magazines_Ltd",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publisher", "http://xmlns.com/foaf/0.1/Agent" ],
  "http://ns.nature.com/terms/name" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "Macmillan Magazines Ltd"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Masato_Kobayashi",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ALL"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#CML"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Colerectal_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Head_and_neck_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Lymphoma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Melanoma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#NSCLC"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Ovarian_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Pancreatic_cancer"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BH3_profiling"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Melanoma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Melanoma"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Melanoma_cell_line",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Melanoma_cell_line"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Methotrexate",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Methotrexate"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Michael_M._Gottesman",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Mitomycin_C",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Mitomycin_C"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Mitoxantrone",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Mitoxantrone"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Multidrug_Resistance_Monitoring_in_Cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Multidrug_Resistance_Monitoring_in_Cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://ns.nature.com/terms/name" : [ {
    "@value" : "Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Multidrug_resistance-MDR_in_cancer_Mechanisms"
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Colerectal_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Lung_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Myeloma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Ovarian_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Renal_cell_cancer"
  } ],
  "https://w3id.org/SKGO/phm#investigatesProblem" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Role_of_P-GP_in_MDR"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Vesicle_transport_experiments"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalProblem" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Multidrug resistance (MDR) efflux pumps capable of\neliminating chemotherapeutic drugs from tumor cells\ncontribute to clinical drug resistance in acute myeloid\nleukemia (AML) and other cancers."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://ns.nature.com/terms/publicationYear" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#gYear",
    "@value" : "2000"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Lawrence_D._Mayer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Rajesh_Krishna"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#European_Journal_of_Pharmaceutical_Sciences"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@language" : "en",
    "@value" : "In recent years, there has been an increased understanding of P-glycoprotein (P-GP)-mediated pharmacokinetic interactions. In addition,\nits role in modifying the bioavailability of orally administered drugs via induction or inhibition has been also been demonstrated in\nvarious studies. This overview presents a background on some of the commonly documented mechanisms of multidrug resistance (MDR),\nreversal using modulators of MDR, followed by a discussion on the functional aspects of P-GP in the context of the pharmacokinetic\ninteractions when multiple agents are coadministered. While adverse pharmacokinetic interactions have been documented with first and\nsecond generation MDR modulators, certain newer agents of the third generation class of compounds have been less susceptible in\neliciting pharmacokinetic interactions. Although the review focuses on P-GP and the pharmacology of MDR reversal using MDR\nmodulators, relevance of these drug transport proteins in the context of pharmacokinetic implications (drug absorption, distribution,\nclearance, and interactions) will also be discussed."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance-MDR_in_cancer_Mechanisms"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://ns.nature.com/terms/publicationYear" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#gYear",
    "@value" : "2003"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#DOUGLAS_D._ROSS"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#L._AUSTIN_DOYLE"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Nature_Publishing_Group"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@language" : "en",
    "@value" : "Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines without overexpression of P-glycoprotein or multidrug resistance protein (MRP) family members\nsuggested the existence of another ATP-binding cassette (ABC) transporter capable of causing cancer drug resistance. In one such cell line (MCF-7/AdrVp), the overexpression of a novel member of the G subfamily of ABC transporters was found. The new transporter was termed the breast cancer resistance protein (BCRP), because of its identification in MCF-7 human breast carcinoma cells. BCRP is a 655 amino-acid polypeptide, formally designated as ABCG2. Like all members of the ABC G (white) subfamily, BCRP is a half transporter. Transfection and enforced overexpression of BCRP in drug-sensitive MCF-7 or MDA-MB-231 cells recapitulates the drug-resistance phenotype of MCF-7/AdrVp cells, consistent with current evidence suggesting that\nfunctional BCRP is a homodimer. BCRP maps to chromosome 4q22, downstream from a TATA-less promoter. The spectrum of anticancer drugs effluxed by BCRP includes mitoxantrone, camptothecin-derived and\nindolocarbazole topoisomerase I inhibitors, methotrexate, flavopiridol, and quinazoline ErbB1 inhibitors. Transport of anthracyclines is variable and appears to depend on the presence of a BCRP mutation at codon 482. Potent and\nspecific inhibitors of BCRP are now being developed, opening the door to clinical applications of BCRP inhibition. Owing to tissue localization in the placenta, bile canaliculi, colon, small bowel, and brain microvessel endothelium, BCRP may play a role in protecting the organism from potentially harmful xenobiotics. BCRP expression has also been demonstrated in pluripotential side population stem cells, responsible for the characteristic ability of these cells to exclude Hoechst 33342 dye, and possibly for the maintenance of the stem cell\nphenotype. Studies are emerging on the role of BCRP expression in drug resistance in clinical cancers. More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional\nassays, in order to determine the contribution of BCRP to drug resistance in human cancers."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A procedure done in order to discover or demonstrate some fact or general truth."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Experiment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A procedure done in order to discover or demonstrate some fact or general truth."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Multiple_chemotherapeutic_agents",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalProblem" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Multiple_chemotherapeutic_agents"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult10",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult11",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult12",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult13",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult14",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult15",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult16",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult17",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult18",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult19",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult20",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#MutationResult9",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Myeloma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Myeloma"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#NSCLC",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "NSCLC"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#NSCLC_cell_lines",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "NSCLC_cell_lines"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#NSCLC_sample",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "NSCLC_sample"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfromPatient" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#National_Cancer_Institute",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Organization" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Nature_Publishing_Group",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publisher", "http://xmlns.com/foaf/0.1/Agent" ],
  "http://ns.nature.com/terms/name" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "Nature Publishing Group"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Neck_squamous_cell_carcinoma_cell_lines",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Neck_squamous_cell_carcinoma_cell_lines"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Neuroblastoma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Neuroblastoma"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Neuroblastoma_Cell",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Neuroblastoma_Cell"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfrom" : [ {
    "@id" : "https://w3id.org/SKGO/phm#American_Type_Culture_Collection"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Neuroepithelioma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Neuroepithelioma"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Nilotinib",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Nilotinib"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Non-P-gp MDR contributed to negative results with zosuquidar in AML trials\nlike ECOG-ACRIN E3999"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Non_Smallcell_Lung_Cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Non_Smallcell_Lung_Cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#NorthernBlotting",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A technique used to detect a specific mRNA sequence, which consists of electrophoresing RNA fragments, transferring those fragments to a membrane, then adding a labelled nucleic acid probe to the milieu."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "NorthernBlotting"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BlotAnalysis"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A technique used to detect a specific mRNA sequence, which consists of electrophoresing RNA fragments, transferring those fragments to a membrane, then adding a labelled nucleic acid probe to the milieu."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Northern_analysis_of_the_expression_of_BCRP_mRNA",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#NorthernBlotting" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Northern_analysis_of_the_expression_of_BCRP_mRNA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ObservationalStudy",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Observational studies are ones where researchers observe the effect of a risk factor, diagnostic test, treatment or other intervention without trying to change who is or isn't exposed to it."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "Observational studies are ones where researchers observe the effect of a risk factor, diagnostic test, treatment or other intervention without trying to change who is or isn't exposed to it."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ObservationalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#StudyDesign"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Observational studies are ones where researchers observe the effect of a risk factor, diagnostic test, treatment or other intervention without trying to change who is or isn't exposed to it."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "ObservationalStudy"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Observational_Study",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ObservationalStudy" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Observational Study"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Ovarian_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Ovarian_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://purl.org/dc/terms/description" : [ {
    "@value" : "The focus of this review is P-GP-mediated MDR, a general overview of the underlying mechanisms and types of drug resistance is presented in the context of the overall MDR phenomenon."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#PGP/MDR1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "PGP/MDR1"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Paclitaxel",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Paclitaxel"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Pancreatic_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Pancreatic_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Pancreatic_cancer_cell_lines",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#CellLine" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Pancreatic_cancer_cell_lines"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Patient",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A person who is under medical care or treatment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Patient"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A person who is under medical care or treatment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Patient_with_adrenocortical_cancer_and_breast_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Patient" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Patient_with_adrenocortical_cancer_and_breast_cancer"
  } ],
  "https://w3id.org/SKGO/phm#hasDisease" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Adrenocortical_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  } ],
  "https://w3id.org/SKGO/phm#has_Treatment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Patrick_G._Johnston",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Peripheral_blood_lymphocytes",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Peripheral_blood_lymphocytes"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfromPatient" : [ {
    "@id" : "https://w3id.org/SKGO/phm#10_patients_with_acute_lymphocytic_leukemia"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Patient" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Phase_III_clinical_trials_with_ABC_transporter_inhibitors"
  } ],
  "https://w3id.org/SKGO/phm#hasDisease" : [ {
    "@id" : "https://w3id.org/SKGO/phm#AML"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Lung_cancer"
  } ],
  "https://w3id.org/SKGO/phm#has_Treatment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Phase_II_clinical_trials_in_patients",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Patient" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Phase_II_clinical_trials_in_patients"
  } ],
  "https://w3id.org/SKGO/phm#hasDisease" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Colerectal_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Lung_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Myeloma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Ovarian_cancer"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Renal_cell_cancer"
  } ],
  "https://w3id.org/SKGO/phm#has_Treatment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Pheochromocytoma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Pheochromocytoma"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Podophyllotoxin",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Podophyllotoxin"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Podophyllotoxin-etoposide_teniposide",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Podophyllotoxin-etoposide_teniposide"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Poor-risk_acute_leukaemia_samples",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Poor-risk_acute_leukaemia_samples"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfromPatient" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Prazocin",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Prazocin"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Probe",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Probe"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A radioactive or chemiluminescent DNA or RNA fragment used to detect the presence of a complementary fragment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Proc._Nati._Acad._Sci._USA",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publisher", "http://xmlns.com/foaf/0.1/Agent" ],
  "http://ns.nature.com/terms/name" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "Proc. Nati. Acad. Sci. USA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Promega_Biotec",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Organization" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#RNA_Fingerprinting",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "RNA_Fingerprinting"
  } ],
  "https://w3id.org/SKGO/phm#hasBlotAnalysis" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Northern_analysis_of_the_expression_of_BCRP_mRNA"
  } ],
  "https://w3id.org/SKGO/phm#useAssay" : [ {
    "@id" : "https://w3id.org/SKGO/phm#RT-PCR_assay"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Sulforhodamine-B_cytotoxicity_assay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"
  } ],
  "https://w3id.org/SKGO/phm#hasTreatment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Functions_of_ABC_transporters_in_Chemotherapy"
  } ],
  "https://w3id.org/SKGO/phm#useAssay" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Surrogate_Assay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#RT-PCR_assay",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "RT-PCR_assay"
  } ],
  "https://w3id.org/SKGO/phm#useGene" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Drosophila_white_gene"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Rajesh_Krishna",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Reagent",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Reagent"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A substance used to produce a chemical reaction so as to detect, measure, or produce other substances."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Refractory_AML_high-risk_MDS_sample",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Refractory_AML_high-risk_MDS_sample"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfromPatient" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Relapsed_and_refractory_AML_sample",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Specimen" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Relapsed_and_refractory_AML_sample"
  } ],
  "https://w3id.org/SKGO/phm#obtainedfromPatient" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Renal_cell_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Renal_cell_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ReviewStudy",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Reviews are a type of literature review that uses systematic methods to collect secondary data, critically appraise research studies, and synthesize findings qualitatively or quantitatively."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ReviewStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#StudyDesign"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Reviews are a type of literature review that uses systematic methods to collect secondary data, critically appraise research studies, and synthesize findings qualitatively or quantitatively."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Review_Study",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ReviewStudy" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Review Study"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Rhabdomyosarcoma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Rhabdomyosarcoma"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Role_of_P-GP_in_MDR",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalProblem" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Role_of_P-GP_in_MDR"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Ryuichi_Nishii",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Sandra_Van_Schaeybroeck",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Sarcoma",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Sarcoma"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Slot_Blot_Analysis",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#BlotAnalysis" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Small_Cell_Lung_Cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Small_Cell_Lung_Cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#SouthernBlotting",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "SouthernBlotting"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BlotAnalysis"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Southern_Blot_Analysis",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#SouthernBlotting" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Southern_Blot_Analysis"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Specimen",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Specimen"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A small sample or part taken to show the nature of the whole, such as a small quantity of urine for urinalysis or a small fragment of tissue for microscopic study."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Springer_Science+Business_Media_LLC",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publisher" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#StatisticalAnalysis",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Statistical methods involved in carrying out a study include planning, designing, collecting data, analysing, drawing meaningful interpretation and reporting of the research findings."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "Statistical methods involved in carrying out a study include planning, designing, collecting data, analysing, drawing meaningful interpretation and reporting of the research findings."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "StatisticalAnalysis"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Statistical methods involved in carrying out a study include planning, designing, collecting data, analysing, drawing meaningful interpretation and reporting of the research findings."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "StatisticalAnalysis"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Study",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A detailed investigation and analysis of a subject or situation."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A detailed investigation and analysis of a subject or situation."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "Study"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#StudyDesign",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Study design is the formulation of trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "StudyDesign"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Study design is the formulation of trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Sulforhodamine-B_cytotoxicity_assay",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Sulforhodamine-B_cytotoxicity_assay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Surrogate_Assay",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Assay" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Surrogate_Assay"
  } ],
  "https://w3id.org/SKGO/phm#hasAssayMethod" : [ {
    "@language" : "en",
    "@value" : "This assay uses flow cytometry to test the ability of human CD56+ cells \nwhich express high levels of the efflux pump P-glycoprotein (PGP)  to retain the PGP substrate rhodamine after exposure to the efflux pump inhibitor PSC-833."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Susan_E._Bates",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TAMMY_KROGMANN",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Takafumi_Tsujiuchi",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Takeo_Nakanishi",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod10",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod11",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod12",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod13",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod14",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod15",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod16",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod17",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod18",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod19",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod20",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TargetingMethod9",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Targeting_multidrug_resistance_in_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://ns.nature.com/terms/Publication", "http://purl.org/ontology/bibo/Article" ],
  "http://ns.nature.com/terms/publicationYear" : [ {
    "@type" : "http://www.w3.org/2001/XMLSchema#gYear",
    "@value" : "2006"
  } ],
  "http://purl.org/dc/terms/creator" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Catherine_Booth-Genthe"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Gergely_Szakcs"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Jill_K._Paterson"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Joseph_A._Ludwig"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Michael_M._Gottesman"
  } ],
  "http://purl.org/dc/terms/publisher" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Nature_Publishing_Group"
  }, {
    "@id" : "https://w3id.org/ScienceOnto/phm#Publisher3"
  } ],
  "http://purl.org/dc/terms/title" : [ {
    "@type" : "http://www.w3.org/2000/01/rdf-schema#Literal",
    "@value" : "Targeting multidrug resistance in cancer"
  } ],
  "http://purl.org/ontology/bibo/abstract" : [ {
    "@language" : "en",
    "@value" : "Effective treatment of metastatic cancers usually requires the use of toxic\nchemotherapy. In most cases, multiple drugs are used, as resistance to single agents occurs almost universally. For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chemical structures  multidrug resistance  has been a major goal of cancer biologists during the past 35 years. Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters. We describe various approaches\nto combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters."
  } ],
  "https://w3id.org/SKGO/phm#addressesStudy" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Taurocholate",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Taurocholate"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Taxenes-paclitaxel_docetaxel",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Taxenes-paclitaxel_docetaxel"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Teniopside",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Teniopside"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Testicular_cancer",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Disease" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Testicular_cancer"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The new transporter was\ntermed the breast cancer resistance protein (BCRP),\nbecause of its identification in MCF-7 human breast\ncarcinoma cells."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ClinicalStudy" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "The_physiological_functions_and_structures_of_ABC_transporters"
  } ],
  "https://w3id.org/SKGO/phm#hasStudyDesign" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Review_Study"
  } ],
  "https://w3id.org/SKGO/phm#investigate" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Breast_Cancer"
  } ],
  "https://w3id.org/SKGO/phm#performsExperiment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Endogenous_and_exogenous_substrates_for_ABC_transporters"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The physiological functions and structures of ABC transporters, and\ndevelopment of chemosensitizers are described focusing\non well-known proteins including Pgp, MRP, and BCRP."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization10",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization11",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization12",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization13",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization14",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization15",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization16",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization17",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization18",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization19",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization20",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TissueLocalization9",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Tito_Fojo",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Topotecan",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Topotecan"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Trastuzumab",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Trastuzumab"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Treatment",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A period in a clinical study during which subjects receive therapeutic treatment or an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Treatment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A period in a clinical study during which subjects receive therapeutic treatment or an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome10",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome11",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome12",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome13",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome14",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome15",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome16",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome17",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome18",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome19",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome2",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome20",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome3",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome4",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome5",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome6",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome7",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome8",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#TreatmentOutcome9",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#VAD",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "VAD"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Vemurafenib",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Vemurafenib"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Verapamil",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Verapamil"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Vesicle_transport_experiments",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Vesicle_transport_experiments"
  } ],
  "https://w3id.org/SKGO/phm#hasTreatment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Daunomycin"
  } ],
  "https://w3id.org/SKGO/phm#useProbe" : [ {
    "@id" : "https://w3id.org/SKGO/phm#cDNA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Vincristine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Vincristine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Vindesine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Vindesine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#WEIDONG_YANG",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#WesternBlotting",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "WesternBlotting"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BlotAnalysis"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Western_Blot_Analysis",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#WesternBlotting" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Western_Blot_Analysis"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#YONGMING_GAO",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Yuya_Okui",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "http://xmlns.com/foaf/0.1/Person" ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Zidovudine",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Zidovudine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Zosuquidar",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Zosuquidar"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#Zosuquidar_AML_experiments",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "Zosuquidar_AML_experiments"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentMethod" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Comparative_CD34+_blast_responses_were_examined"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentalResult" : [ {
    "@language" : "en",
    "@value" : "50 AML specimens for MDR function\nusing zosuquidar, a P-gp-selective modulator, and two\nex vivo leukemic blast bioassays confirms the heterogeneous\nnature of MDR efflux pump function by AML\nblasts. Moreover, it supports the supposition that function\nof multiple transporters could have circumvented\nor obscured efficacy of P-gp modulators in AML clinical\ntrials like E3999 with zosuquidar."
  } ],
  "https://w3id.org/SKGO/phm#useCellLine" : [ {
    "@id" : "https://w3id.org/SKGO/phm#CD34+_Leukemic_Blasts"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Zosuquidar"
  } ],
  "https://w3id.org/SKGO/phm#useReagent" : [ {
    "@id" : "https://w3id.org/SKGO/phm#DiOC2"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Fluorochrome-labeled_anti-CD_antibodies"
  } ],
  "https://w3id.org/SKGO/phm#useSpecimen" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Bone_marrow_aspirates"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#addressesStudy",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "To give attention to or deal with a research or study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "http://ns.nature.com/terms/Publication"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "addressesStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "To give attention to or deal with a research or study."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#antibody-mediated_cytolysis_experiment",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "antibody-mediated_cytolysis_experiment"
  } ],
  "https://w3id.org/SKGO/phm#hasTreatment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"
  } ],
  "https://w3id.org/SKGO/phm#useAssay" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Functional_Assay"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#assayTitle",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Title of the assay."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Assay"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "assayTitle"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@value" : "Title of the assay."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#cDNA",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Probe" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "cDNA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#ex_vivo",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#ex_vivo" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Outside the living body; denoting removal of an organ (e.g., the kidney) for reparative surgery, after which it is returned to the original site."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ex_vivo"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentSetting"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Outside the living body; denoting removal of an organ (e.g., the kidney) for reparative surgery, after which it is returned to the original site."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#examinedBy",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#ReflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "To look at or consider a statement carefully and in detail in order to explore and discover."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid4"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "examinedBy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "To look at or consider a statement carefully and in detail in order to explore and discover."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#failureReason",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The reasons or causes of a condition or  a fact of not achieving the desired end or ends."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Treatment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "failureReason"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2001/XMLSchema#string"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The reasons or causes of a condition or  a fact of not achieving the desired end or ends."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasAssayMethod",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Methods used in Assay."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#comment" : [ {
    "@language" : "en",
    "@value" : "Methods used in Assay."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Assay"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasAssayMethod"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Methods used in Assay."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "hasAssayMethod"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasBlotAnalysis",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Experiment uses as a method for the transfer of protein, RNA or DNA molecules."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useBlotAnalysis"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#BlotAnalysis"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Experiment uses as a method for the transfer of protein, RNA or DNA molecules."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasClinicalProblem",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Problem or a difficulty, disorder, condition occurs in Clinical Study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Treatment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Problem or a difficulty, disorder, condition occurs in Clinical Study."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasDisease",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Person who shows a definite pathological process having a characteristic set of signs and symptoms."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Patient"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasDisease"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Disease"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Person who shows a definite pathological process having a characteristic set of signs and symptoms."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasDrugEffects",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The ability of a drug or treatment to produce a specific result."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Drug"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasDrugEffects"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The ability of a drug or treatment to produce a specific result."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "hasDrugEffects"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasEligibilityCriteria",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Eligibility criteria for treatment studies often require that patients have a particular type and stage of disease."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid37"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasEligibilityCriteria"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Eligibility criteria for treatment studies often require that patients have a particular type and stage of disease."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "hasEligibilityCriteria"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasEvidence",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Information, including verifiable facts and data that support a practice or belief."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasEvidence"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Information, including verifiable facts and data that support a practice or belief."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasExperiment",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Study has a procedure done in order to discover or demonstrate some fact or general truth"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasExperiment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Study has a procedure done in order to discover or demonstrate some fact or general truth"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasExperimentKit",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Identification of the kit/biologicals used in the experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasExperimentKit"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentKit"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Identification of the kit/biologicals used in the experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasExperimentMaterial",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Experiment has materials are culture collections and chemicals used for executing of an experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasExperimentMaterial"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentMaterial"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Experiment has materials are culture collections and chemicals used for executing of an experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasExperimentMethod",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "An experiment has method is a way to solve a scientific task by executing a scientific experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasExperimentMethod"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Antibody-mediated_cytolysis_experiment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "An experiment has method is a way to solve a scientific task by executing a scientific experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasExperimentalResult",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Identification of Experimental results that are the set of facts and conclusions."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasExperimentalResult"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Identification of Experimental results that are the set of facts and conclusions."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "hasExperimentalResult"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasExperimentalSetting",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Experiment identifies the designed experiment involves the investigator assigning some or all conditions to subjects."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasExperimentSetting"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentSetting"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Experiment identifies the designed experiment involves the investigator assigning some or all conditions to subjects."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasFindings",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A conclusion reached after examination or investigation."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasFindings"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A conclusion reached after examination or investigation."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "hasFindings"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasHypothesis",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Referencing a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasResearchStatement"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Referencing a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasInvestigation",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Study which acts or processes of examining."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasInvestigation"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Investigation"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Study which acts or processes of examining."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasLimitations",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Conditions or restrictions of research study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasLimitations"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Conditions or restrictions of research study."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasMutationResult",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The result of an alteration or change, as in nature, form, or quality."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasMutationResult"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The result of an alteration or change, as in nature, form, or quality."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "hasMutationResult"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasOverexpressionGene",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The Gene that has overexpression which leads to the abundant target protein expression subsequently."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasOverexpressionGene"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The Gene that has overexpression which leads to the abundant target protein expression subsequently."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasProblemSolution",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Problem has the answer  or the explanation for something."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasProblemSolution"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Problem has the answer  or the explanation for something."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasProtein",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Referencing any of a group of complex organic macromolecules ."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Cell"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasProtein"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Gene"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Referencing any of a group of complex organic macromolecules ."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasStudyDesign",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Clinical Study defines the study design for the trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasStudyDesign"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#StudyDesign"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Clinical Study defines the study design for the trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasSuggestion",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "An idea is induced in or adopted by another without argument, command, or coercion."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasSuggestion"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "An idea is induced in or adopted by another without argument, command, or coercion."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "hasSuggestion"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasTargetingMethod",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The process of having proteins contain certain signals such that the proteins are directed specifically towards certain cellular locations"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasTargetingMethod"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The process of having proteins contain certain signals such that the proteins are directed specifically towards certain cellular locations"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasTissueLocalization",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A determination of the tissue place of proteins, genes."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasTissueLocalization"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2001/XMLSchema#string"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A determination of the tissue place of proteins, genes."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "hasTissueLocalization"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasTitle",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A name that describes something."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid40"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasTitle"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A name that describes something."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#hasTreatment",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Defining a period in a clinical study during which subjects receive therapeutic treatment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid7"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useTreatment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Treatment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Defining a period in a clinical study during which subjects receive therapeutic treatment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#has_Treatment",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Disease that has a therapeutic treatment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Disease"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "hasTreatment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Treatment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Disease that has a therapeutic treatment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#identify_and_overcome_underlying_mechanisms_of_resistance",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "identify_and_overcome_underlying_mechanisms_of_resistance"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "this Review focuses on the mechanisms that enable the survival of cancer\ncells during drug treatment and on current research\nefforts to identify and overcome underlying mechanisms\nof resistance to both standard chemotherapeutic agents\nand molecularly targeted therapies."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#in_silico",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#in_silico" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "The mimicking or modeling of biological processes within computer hardware and software."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "in_silico"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentSetting"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "The mimicking or modeling of biological processes within computer hardware and software."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#in_vitro",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#in_vitro" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "In an artificial environment, referring to a process or reaction occurring therein, as in a test tube or culture media."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "in_vitro"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentSetting"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "In an artificial environment, referring to a process or reaction occurring therein, as in a test tube or culture media."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#in_vivo",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class", "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#in_vivo" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Biological processes or experiments occurring in the living organism."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "in_vivo"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ExperimentSetting"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Biological processes or experiments occurring in the living organism."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#inhibitors_NB-506_J-107088",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "inhibitors_NB-506_J-107088"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#investigate",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#ReflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "To observe or inquire into in detail; examine systematically."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "investigate"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Disease"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "To observe or inquire into in detail; examine systematically."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#investigatesProblem",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "To examine an issue, problem, statement of research or study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "investigatesProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalProblem"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "To examine an issue, problem, statement of research or study."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#isClinicalTrial",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#SymmetricProperty", "http://www.w3.org/2002/07/owl#ReflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Patients are chosen as Clinical Trial for Clinical Study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Patient"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "isClinicalTrial"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalTrial"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Patients are chosen as Clinical Trial for Clinical Study."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#levels_of_mdr1_mRNA",
  "@type" : [ "http://www.w3.org/2002/07/owl#Class" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "It is a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "ResearchStatement"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subClassOf" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Study"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "It is a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#mdr1",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Gene" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "MDR1"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#mdr1_gene_expression",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "mdr1_gene_expression"
  } ],
  "https://w3id.org/SKGO/phm#hasBlotAnalysis" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Slot_Blot_Analysis"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentalResult" : [ {
    "@language" : "en",
    "@value" : "Expression of mdr1 in Tumors from Untreated and Treated Patients"
  } ],
  "https://w3id.org/SKGO/phm#hasTreatment" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Cancer_chemotherapy_doxorubicin_vinblastine"
  } ],
  "https://w3id.org/SKGO/phm#name" : [ {
    "@language" : "en",
    "@value" : "Mdr1 Hybridization Probes, RNA Extraction, Electrophoresis"
  } ],
  "https://w3id.org/SKGO/phm#useCellLine" : [ {
    "@id" : "https://w3id.org/SKGO/phm#CCL_127__PC12"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Colon_carcinoma"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#HTB_10_HTB_11_HTB_38"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#KB-3-1_KB-8-5_KB-V1"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Actinomycin_D"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Doxorubicin"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Mitomycin_C"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Vincristine"
  } ],
  "https://w3id.org/SKGO/phm#useGene" : [ {
    "@id" : "https://w3id.org/SKGO/phm#mdr1"
  } ],
  "https://w3id.org/SKGO/phm#useProbe" : [ {
    "@id" : "https://w3id.org/SKGO/phm#cDNA"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#multidrug_resistance_to_cancer_cells",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "multidrug_resistance_to_cancer_cells"
  } ],
  "https://w3id.org/SKGO/phm#hasExperimentMethod" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"
  } ],
  "https://w3id.org/SKGO/phm#name" : [ {
    "@value" : "Transfection Experiments"
  } ],
  "https://w3id.org/SKGO/phm#useCellLine" : [ {
    "@id" : "https://w3id.org/SKGO/phm#CD56+"
  } ],
  "https://w3id.org/SKGO/phm#useDrug" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Anthranilic-acid-based_drug"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Immunosuppressant_cyclosporin_A"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Mitoxantrone"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Paclitaxel"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#Verapamil"
  } ],
  "https://w3id.org/SKGO/phm#useGene" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ABCA2"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MDR2"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP1"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP2"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP3"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP4"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP5"
  }, {
    "@id" : "https://w3id.org/SKGO/phm#MRP6"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#name",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A word or words by which an entity is designated and distinguished from others."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid43"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2001/XMLSchema#string"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A word or words by which an entity is designated and distinguished from others."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#obtainedfrom",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Get, acquire, or secure something."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid10"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "obtainedfrom"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://xmlns.com/foaf/0.1/Organization"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Get, acquire, or secure something."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#obtainedfromPatient",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Get, acquire, or secure specimen from patient."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Specimen"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "obtainedfromPatient"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Patient"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Get, acquire, or secure specimen from patient."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#performsExperiment",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Clinical Study performs particular Experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "performsExperiment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Clinical Study performs particular Experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#refersExperiment",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "To relate investigation to a particular Experiment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Investigation"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "refersExperiment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "To relate investigation to a particular Experiment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#resistantTo",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Cell definitions resistant to drugs."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Cell"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "resistantTo"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Drug"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Cell definitions resistant to drugs."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#testOn",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "To prove; to try a substance; to determine the chemical nature of a substance on Patient."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Drug"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "testOn"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalTrial"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "To prove; to try a substance; to determine the chemical nature of a substance on Patient."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#topoisomerase_I",
  "@type" : [ "http://www.w3.org/2002/07/owl#NamedIndividual", "https://w3id.org/SKGO/phm#Drug" ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "topoisomerase_I"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#treatmentOutcome",
  "@type" : [ "http://www.w3.org/2002/07/owl#DatatypeProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "A final product or end result of treatment."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Treatment"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "treatmentOutcome"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "http://www.w3.org/2000/01/rdf-schema#Literal"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topDataProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "A final product or end result of treatment."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#useAssay",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Method referencing a assay to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useAssay"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Assay"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Method referencing a assay to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system."
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#useCellLine",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Cell Lines  that are used as material in experimental study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid13"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useCellLine"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#CellLine"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Cell Lines  that are used as material in experimental study."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "useCellLine"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#useDrug",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Drugs that are used as material in experimental study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid16"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useDrug"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Drug"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Drugs that are used as material in experimental study."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "useDrug"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#useGene",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Genes that are used as material in experimental study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid20"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useGene"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Gene"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Genes that are used as material in experimental study."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "useGene"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#useProbe",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Probes that are used as material in experimental study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid23"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useProbe"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Probe"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Probes that are used as material in experimental study."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "useProbe"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#useReagent",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Reagents that are used as material in experimental study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Multidrug_resistance_to_cancer_cells"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useReagent"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Reagent"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Reagents that are used as material in experimental study."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "useReagent"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#useSpecimen",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Specimen that are used as material in experimental study."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "_:genid26"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useSpecimen"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#Specimen"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Specimen that are used as material in experimental study."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "Specimen that are used as material in experimental study."
  }, {
    "@language" : "en",
    "@value" : "useSpecimen"
  } ]
}, {
  "@id" : "https://w3id.org/SKGO/phm#useStatisticalAnalysis",
  "@type" : [ "http://www.w3.org/2002/07/owl#ObjectProperty", "http://www.w3.org/2002/07/owl#AsymmetricProperty", "http://www.w3.org/2002/07/owl#IrreflexiveProperty", "http://www.w3.org/2002/07/owl#NamedIndividual" ],
  "http://purl.org/dc/elements/1.1/description" : [ {
    "@language" : "en",
    "@value" : "Study uses statistical analysis involves collecting and scrutinizing every data sample in a set of items from which samples can be drawn."
  } ],
  "http://www.w3.org/2000/01/rdf-schema#domain" : [ {
    "@id" : "https://w3id.org/SKGO/phm#ClinicalStudy"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#label" : [ {
    "@language" : "en",
    "@value" : "useStatisticalAnalysis"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#range" : [ {
    "@id" : "https://w3id.org/SKGO/phm#StatisticalAnalysis"
  } ],
  "http://www.w3.org/2000/01/rdf-schema#subPropertyOf" : [ {
    "@id" : "http://www.w3.org/2002/07/owl#topObjectProperty"
  } ],
  "http://www.w3.org/2004/02/skos/core#definition" : [ {
    "@language" : "en",
    "@value" : "Study uses statistical analysis involves collecting and scrutinizing every data sample in a set of items from which samples can be drawn."
  } ],
  "http://xmlns.com/foaf/0.1/name" : [ {
    "@language" : "en",
    "@value" : "useStatisticalAnalysis"
  } ]
} ]